Plante Moran Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $135K | Sell |
269
-168
| -38% | -$80.6K | 0.01% | 208 |
|
|
2026
Q1 | $215K | Sell |
437
-31
| -7% | -$16.8K | 0.01% | 153 |
|
|
2025
Q4 | $271K | Buy |
468
+9
| +2% | +$5.09K | 0.02% | 139 |
|
|
2025
Q3 | $223K | Sell |
459
-98
| -18% | -$45.6K | 0.01% | 157 |
|
|
2025
Q2 | $226K | Buy |
557
+436
| +360% | +$182K | 0.02% | 151 |
|
|
2025
Q1 | $60.2K | Buy |
121
+8
| +7% | +$4.33K | 0.01% | 310 |
|
|
2024
Q4 | $58.8K | Sell |
113
-17
| -13% | -$9.35K | ﹤0.01% | 322 |
|
|
2024
Q3 | $80.4K | Sell |
130
-6
| -4% | -$3.55K | 0.01% | 312 |
|
|
2024
Q2 | $75.2K | Buy |
136
+6
| +5% | +$3.44K | 0.01% | 279 |
|
|
2024
Q1 | $75.6K | Hold |
130
| – | – | 0.01% | 282 |
|
|
2023
Q4 | $69K | Sell |
130
-8
| -6% | -$3.87K | 0.01% | 286 |
|
|
2023
Q3 | $69.9K | Buy |
138
+25
| +22% | +$13.3K | 0.01% | 261 |
|
|
2023
Q2 | $59K | Hold |
113
| – | – | 0.01% | 281 |
|
|
2023
Q1 | $65.1K | Sell |
113
-69
| -38% | -$38.9K | 0.01% | 263 |
|
|
2022
Q4 | $100K | Sell |
182
-40
| -18% | -$21.2K | 0.01% | 229 |
|
|
2022
Q3 | $113K | Buy |
222
+46
| +26% | +$25.7K | 0.02% | 197 |
|
|
2022
Q2 | $96K | Sell |
176
-41
| -19% | -$22.6K | 0.02% | 219 |
|
|
2022
Q1 | $128K | Sell |
217
-206
| -49% | -$118K | 0.02% | 207 |
|
|
2021
Q4 | $282K | Buy |
423
+94
| +29% | +$58.7K | 0.05% | 147 |
|
|
2021
Q3 | $188K | Buy |
329
+79
| +32% | +$43.4K | 0.04% | 192 |
|
|
2021
Q2 | $126K | Sell |
250
-697
| -74% | -$329K | 0.03% | 222 |
|
|
2021
Q1 | $432K | Buy |
947
+521
| +122% | +$249K | 0.12% | 87 |
|
|
2020
Q4 | $198K | Buy |
426
+115
| +37% | +$53.9K | 0.06% | 170 |
|
|
2020
Q3 | $137K | Buy |
311
+18
| +6% | +$7.44K | 0.05% | 200 |
|
|
2020
Q2 | $106K | Buy |
293
+206
| +237% | +$69K | 0.04% | 202 |
|
|
2020
Q1 | $25K | Sell |
87
-17
| -16% | -$5.36K | 0.01% | 353 |
|
|
2019
Q4 | $34K | Buy |
104
+3
| +3% | +$910 | 0.01% | 382 |
|
|
2019
Q3 | $29K | Hold |
101
| – | – | 0.01% | 426 |
|
|
2019
Q2 | $30K | Buy |
101
+6
| +6% | +$1.65K | 0.01% | 428 |
|
|
2019
Q1 | $26K | Sell |
95
-133
| -58% | -$33.1K | 0.01% | 435 |
|
|
2018
Q4 | $51K | Sell |
228
-102
| -31% | -$23.9K | 0.02% | 283 |
|
|
2018
Q3 | $81K | Sell |
330
-11
| -3% | -$2.53K | 0.03% | 236 |
|
|
2018
Q2 | $71K | Sell |
341
-565
| -62% | -$120K | 0.04% | 269 |
|
|
2018
Q1 | $187K | Buy |
906
+35
| +4% | +$7.35K | 0.1% | 155 |
|
|
2017
Q4 | $165K | Buy |
871
+563
| +183% | +$108K | 0.09% | 162 |
|
|
2017
Q3 | $58K | Sell |
308
-4
| -1% | -$724 | 0.03% | 275 |
|
|
2017
Q2 | $54K | Sell |
312
-61
| -16% | -$10.2K | 0.03% | 294 |
|
|
2017
Q1 | $57K | Sell |
373
-691
| -65% | -$106K | 0.03% | 294 |
|
|
2016
Q4 | $150K | Buy |
1,064
+878
| +472% | +$129K | 0.09% | 161 |
|
|
2016
Q3 | $30K | Sell |
186
-17
| -8% | -$2.62K | 0.02% | 407 |
|
|
2016
Q2 | $30K | Buy |
203
+42
| +26% | +$6.2K | 0.02% | 366 |
|
|
2016
Q1 | $23K | Sell |
161
-113
| -41% | -$15.1K | 0.02% | 365 |
|
|
2015
Q4 | $39K | Sell |
274
-10
| -4% | -$1.33K | 0.03% | 333 |
|
|
2015
Q3 | $35K | Sell |
284
-2
| -0.7% | -$261 | 0.03% | 317 |
|
|
2015
Q2 | $37K | Sell |
286
-2
| -0.7% | -$261 | 0.03% | 338 |
|
|
2015
Q1 | $39K | Hold |
288
| – | – | 0.03% | 316 |
|
|
2014
Q4 | $36K | Hold |
288
| – | – | 0.03% | 326 |
|
|
2014
Q3 | $35K | Sell |
288
-18
| -6% | -$2.19K | 0.03% | 308 |
|
|
2014
Q2 | $36K | Buy |
306
+261
| +580% | +$30.7K | 0.03% | 281 |
|
|
2014
Q1 | $5K | Sell |
45
-210
| -82% | -$25K | 0.01% | 475 |
|
|
2013
Q4 | $28K | Sell |
255
-210
| -45% | -$20.9K | 0.02% | 308 |
|
|
2013
Q3 | $43K | Hold |
465
| – | – | 0.03% | 205 |
|
|
2013
Q2 | $39K | Buy |
+465
| New | +$38.7K | 0.03% | 189 |
|
Other funds holding TMO
Plante Moran Financial Advisors's TMO Position: Q2 2026 in Review
Plante Moran Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 38% in Q2 2026, selling an estimated $80.6K and leaving 269 shares worth $135K. The position accounts for 0.01% of the portfolio, ranked #208.
Plante Moran Financial Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $432K in Q1 2021. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Plante Moran Financial Advisors held 269 shares of Thermo Fisher Scientific worth $135K as of Q2 2026.
- Plante Moran Financial Advisors sold 168 Thermo Fisher Scientific shares in Q2 2026, an estimated $80.6K.
- Thermo Fisher Scientific made up 0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #208 holding.
- Plante Moran Financial Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Plante Moran Financial Advisors's Thermo Fisher Scientific position peaked at $432K in Q1 2021.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.